Presented:

NeoGenomics Reports Record Revenue of $67.7 Million with 14% Increase in Clinical Volume Growth and 95% Increase in Pharma Services Backlog

Read Now

Presented:

NeoGenomics Schedules its Second Quarter Earnings Release for July 24, 2018

Read Now

Presented:

NeoGenomics Redeems 100% of Series A Redeemable Preferred Stock

Read Now

Presented:

PPD and NeoGenomics Forming Global Strategic Alliance for Pathology and Molecular Testing Solutions

Read Now

Presented:

NeoGenomics to Participate In Two Upcoming Investor Conferences

Read Now

Presented:

NeoGenomics Reports Revenue of $63.4 Million, Net Income of $0.6 Million and Adjusted EBITDA of $9.2 Million in the First Quarter of 2018

Read Now

Presented:

NeoGenomics Schedules its First Quarter Earnings Release for May 1, 2018

Read Now

Presented:

NeoGenomics Announces Executive Appointments

Read Now

Presented:

NeoGenomics Reports Revenue of $67.8 Million on 18.7% Clinical Volume Growth and $10.5 Million of Adjusted EBITDA in the Fourth Quarter of 2017

Read Now

Presented:

NeoGenomics Schedules its Fourth Quarter and Fiscal Year 2017 Earnings Release for February 21, 2018

Read Now